Article type:
Research
Estimated read time:
3 mins min read
Published:
21/10/2025
This study explores how a specific pathway in the immune system, known as the STING pathway, can trigger a type of cell death called necroptosis through a protein called ZBP1. This occurs without the usual signals from other proteins, suggesting a new way cells can die when they are under stress. The research shows that manipulating this pathway might help treat diseases linked to inflammation and cell death, offering hope for new therapies in the future.
Why it Matters The findings underscore the importance of the STING-ZBP1 pathway in understanding necroptosis, a crucial cell death mechanism that may contribute to various pathological conditions. The ability to manipulate this pathway could lead to innovative treatments for diseases characterized by excessive inflammation and cell death, such as autoimmune disorders and cancer. Additionally, it opens avenues for further research into the signalling networks that govern cell death and immune responses.
Hope for the Future
- There is potential for developing therapies that target the STING-ZBP1 pathway, offering new strategies for treating inflammatory diseases and cancers.
- Future research may explore how modulation of this pathway could alleviate conditions associated with aberrant cell death.
- The findings prompt further investigation into the role of ZBP1 in other immune-related processes, potentially unveiling new biomarkers for disease states.
- Insights from this study could lead to improved understanding and management of diseases driven by necroptosis and inflammation.
Read more
Background The study investigates the role of the STING (Stimulator of Interferon Genes) pathway in inducing necroptosis, a type of programmed cell death, through ZBP1 (Z-DNA binding protein 1) independently of TNFR1 (Tumour Necrosis Factor Receptor 1) and FADD (Fas-Associated protein with Death Domain). This research is particularly relevant due to the implications of necroptosis in various diseases, including inflammation and cancer, where traditional apoptosis pathways may be disrupted.
What the Study Found
- The study demonstrated that the activation of the STING pathway leads to ZBP1-mediated necroptosis.
- This process occurs without the involvement of TNFR1 and FADD, suggesting an alternative signalling mechanism for necroptosis.
- Mice lacking both Caspase-8 and STING exhibited prolonged survival compared to those lacking only Caspase-8, indicating a protective role of ZBP1 in this context.
- The research pinpointed specific genes involved in the necroptosis process, including those related to the immune response and inflammation.
- Inflammation levels were lower in mice that underwent ZBP1-mediated necroptosis, highlighting a potential therapeutic angle for inflammatory diseases.
- The study utilized RNA-seq data for comprehensive genetic analysis, confirming differential expression patterns associated with necroptosis.
Citation Kelepouras et al., Nature (2025). https://doi.org/10.1038/s41586-025-09536-4
Authors Konstantinos Kelepouras, Julia Saggau, Debora Bonasera, Christine Kiefer, Federica Locci, Hassan Rakhsh-Khorshid, Louisa Grauvogel, Ana Beatriz Varanda, Martin Peifer, Elena Loricchio, Antonella Montinaro, Marijana Croon, Aleksandra Trifunovic, Giusi Prencipe, Antonella Insalaco, Fabrizio De Benedetti, Henning Walczak & Gianmaria Liccardi
Date of publication 20/8/25